Problems identified with phase II stopping rules that employ response and early-progression rates
J Clin Oncol
.
2009 Feb 1;27(4):646-7; author reply 647.
doi: 10.1200/JCO.2008.19.9182.
Epub 2008 Dec 22.
Authors
James R Anderson
,
Mark D Krailo
PMID:
19103727
DOI:
10.1200/JCO.2008.19.9182
No abstract available
Publication types
Comment
Letter
MeSH terms
Clinical Trials, Phase II as Topic*
Humans
Models, Theoretical
Research Design